Globus Medical Reports Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Globus Medical (GMED) Reports In-Line Q2 EPS
August 4, 2022 4:59 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $263.6 million versus the consensus estimate of $259.38 million.
GUIDANCE:
Globus Medical sees FY2022 EPS of $2.10, versus the consensus of $2.09.... More
